b 151 (Donepezil (Orally Disintegrating) 5 mg)
Pill imprint b 151 has been identified as Donepezil hydrochloride (orally disintegrating) 5 mg.
Donepezil is used in the treatment of alzheimer's disease; mild cognitive impairment; lewy body dementia and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Donepezil 5 mg is not subject to the Controlled Substances Act.
See also related documents.